Immuneering (NasdaqGM:IMRX) FY Conference Transcript

Immuneering (NasdaqGM:IMRX) FY Conference February 26, 2026 10:00 AM ET Company ParticipantsBen Zeskind - Co-Founder and CEOConference Call ParticipantsJay Olson - Biotechnology Equity Research AnalystJay OlsonHello, everyone, and welcome to Oppenheimer's 36th Annual Healthcare Life Sciences Conference. I'm Jay Olson, one of the biotech analysts here at Oppenheimer, and it's a pleasure to welcome you to our discussion with Immuneering, and it's an honor to introduce Ben Zeskind, CEO and Co-founder of Immune ...